Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis

Rheumatoid arthritis (RA) is an autoimmune disease characterized by systemic synovitis and bone destruction. Proinflammatory cytokines activate pathways of immune-mediated inflammation, which aggravates RA. The mechanistic target of rapamycin (mTOR) signaling pathway associated with RA connects immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fen, Cheng, Ting, Zhang, Sheng-Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544394/
https://www.ncbi.nlm.nih.gov/pubmed/37784141
http://dx.doi.org/10.1186/s13075-023-03181-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544394/
https://www.ncbi.nlm.nih.gov/pubmed/37784141
http://dx.doi.org/10.1186/s13075-023-03181-w

Ejemplares similares